Shire filed suit against Johnson Matthey and Mylan Pharmaceuticals over 16 patents related to abuse-resistant amphetamine prodrugs. 2/2, District of New Jersey, 2:2012cv00638.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
